Pathogenic NF1 truncating mutation and copy number alterations in a dedifferentiated liposarcoma with multiple lung metastasis: a case report.
BMC Med Genet
; 21(1): 200, 2020 10 12.
Article
in En
| MEDLINE
| ID: mdl-33046013
ABSTRACT
BACKGROUND:
Dedifferentiated liposarcoma (DDLPS), which accounts for an estimated 15-20% of liposarcomas, is a high-grade and aggressive malignant neoplasm, exhibiting a poor response to available therapeutic agents. However, genetic alteration profiles of DDLPS as well as the role of NF1 mutations have not been studied extensively. CASE PRESENTATION The current study reports a patient presenting with rapidly growing DDLPS accompanied by multiple lung and pleural metastases, in whom whole-exome sequencing revealed a NF1 truncating mutation of the known pathogenic variant, c.C7486T, p.R2496X, as well as multiple copy number alterations (CNAs), including the well-known 12q13-15 amplification, and multiple chromothripsis events encompassing potential cancer-related genes.CONCLUSIONS:
Our results suggest that, in addition to the 12q13-15 amplification, NF1 inactivation mutation and other CNAs may contribute to DDLPS tumorigenesis accompanied by aggressive clinical features.Key words
Full text:
1
Database:
MEDLINE
Main subject:
Neurofibromin 1
/
DNA Copy Number Variations
/
Liposarcoma
/
Lung Neoplasms
/
Mutation
Limits:
Aged80
/
Humans
/
Male
Language:
En
Year:
2020
Type:
Article